Loading…
Quanterix Corporation is projected to decline to $2.44 by 2027, a -8% move from its current price of $2.65. QTRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.55 | $2.65 | $2.75 | -0.01% |
| May 30 | $2.52 | $2.65 | $2.79 | -0.02% |
| May 31 | $2.49 | $2.65 | $2.82 | -0.02% |
| Jun 1 | $2.46 | $2.65 | $2.85 | -0.03% |
| Jun 2 | $2.44 | $2.65 | $2.87 | -0.04% |
| Jun 3 | $2.42 | $2.65 | $2.90 | -0.05% |
| Jun 4 | $2.40 | $2.65 | $2.92 | -0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.40 | $2.65 | $2.92 | -0.06% |
| Week 2 | $2.31 | $2.65 | $3.04 | -0.11% |
| Week 3 | $2.24 | $2.65 | $3.13 | -0.17% |
| Week 4 | $2.18 | $2.64 | $3.21 | -0.22% |
| Week 5 | $2.13 | $2.64 | $3.28 | -0.28% |
| Week 6 | $2.08 | $2.64 | $3.35 | -0.33% |
| Week 7 | $2.04 | $2.64 | $3.41 | -0.39% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Quanterix Corporation is a life sciences company operating across North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument and SR-X instrument that enable researchers to apply Simoa detection in an expanded range of applications, and SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company’s products include assays that include all components required to run enzyme-based immunoassays, such as beads, capture and detector reagents, and enzyme reagents and substrate, as well as replacement parts, reagents, and antibodies.
It also provides contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in neurology, oncology and immunology, and inflammation, selling its life science products to laboratories at academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research organizations through direct field sales, support organizations, and distributors.
The company was formerly known as Digital Genomics, Inc., and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Quanterix Corporation (QTRX) is currently priced at $2.69 per share, with a market capitalization of $126.72M and a rank of 4118.
The 2026 price outlook shows an average price of $2.69 with neutral sentiment, indicating a flat trajectory near the starting point. The forecast projects growth in the following years, including a 2029 average of $3.68 and a 2050 average of $9.70, with a 2050 maximum forecast of $20.80, suggesting meaningful upside over the long horizon despite year-to-year fluctuations.
These figures reflect an overall long-term upside potential, tempered by near-term variability; investors should treat the forecast as estimates rather than guaranteed outcomes.
A major floor 30.9% below — a decisive break under it would weaken the trend.
The nearest floor, 5.3% below — buyers have tended to step in here.
The nearest ceiling, 35.8% above — a clean break opens room to run.
A major ceiling 179.2% above — clearing it would confirm fresh momentum.
Key QTRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of QTRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.64 | Buy | $2.65 | Sell |
| MA 10 | $2.66 | Sell | $2.70 | Sell |
| MA 20 | $2.87 | Sell | $2.86 | Sell |
| MA 50 | $3.32 | Sell | $3.46 | Sell |
| MA 100 | $4.78 | Sell | $4.26 | Sell |
| MA 200 | $5.25 | Sell | $5.23 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.39 | Neutral |
| Stoch RSI (14) | 86.17 | Sell |
| CCI (20) | -62.75 | Neutral |
| Williams %R (14) | -65.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -6.19 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 35.00 | Neutral |
| TRIX (15) | -1.10 | Sell |
| Awesome (5,34) | -0.43 | Sell |
| Ultimate (7,14,28) | 35.31 | Neutral |
| Momentum (10) | -0.26 | Sell |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 2.68 | Sell |
| ADX (14) | 30.67 | Sell |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is neutral. The RSI(14) stands at 40, signaling neither overbought nor oversold conditions.
The stock’s short-term moving averages show a SMA50 of $3.40 and a SMA200 of $5.28, with near-term support at $2.51 and resistance at $3.60. The 30-day price range spans from a low of $2.08 to a high of $3.48, illustrating a relatively tight trading band around the current price.
Annualized volatility is high at 70%, underscoring elevated swings in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.51 | $2.65 | $3.61 | 0% | Neutral | |
| $1.87 | $2.44 | $3.41 | -8% | Neutral | |
| $2.12 | $2.87 | $4.19 | +8% | Neutral | |
| $2.56 | $3.59 | $5.43 | +35% | Bullish | |
| $2.31 | $3.33 | $5.19 | +26% | Bullish | |
| $2.27 | $3.35 | $5.36 | +26% | Bullish | |
| $2.20 | $3.33 | $5.45 | +26% | Bullish | |
| $1.95 | $3.03 | $5.07 | +14% | Neutral | |
| $2.19 | $3.47 | $5.92 | +31% | Bullish | |
| $2.39 | $3.86 | $6.71 | +46% | Bullish | |
| $2.45 | $4.39 | $8.23 | +66% | Bullish | |
| $4.43 | $9.52 | $19.85 | +259% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.51 | $2.65 | $3.11 | +0.00% |
| June 2026 | $2.15 | $2.55 | $3.10 | -3.93% |
| July 2026 | $2.20 | $2.63 | $3.26 | +3.34% |
| August 2026 | $2.29 | $2.77 | $3.47 | +5.15% |
| September 2026 | $2.25 | $2.73 | $3.47 | -1.26% |
| October 2026 | $2.21 | $2.70 | $3.46 | -1.13% |
| November 2026 | $2.27 | $2.79 | $3.61 | +3.35% |
| December 2026 | $2.23 | $2.76 | $3.61 | -0.94% |
Click any year to see its month-by-month QTRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, QTRX could reach as high as $3.61, with a base case around $2.65 and support toward $2.51 — roughly 0% from $2.65. Price action looks broadly range-bound.
Expect QTRX to range from $1.87 to $3.41 through 2027. The $2.44 average target implies a -8% move from current prices. That is -8% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The QTRX price prediction for 2028 points to an average of $2.87 (low $2.12, high $4.19) — a potential gain of +8% on today's $2.65. Price action looks broadly range-bound.
In 2029, QTRX is projected to trade between $2.56 and $5.43, averaging $3.59 — a potential gain of +35% from today's $2.65. That is up +25% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Quanterix Corporation's 2030 outlook centres on $3.33, within a $2.31 to $5.19 range. That is -7% versus the projected 2029 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2031, QTRX could reach as high as $5.36, with a base case around $3.35 and support toward $2.27 — roughly +26% from $2.65. Buyers look set to stay in control over this stretch.
Expect QTRX to range from $2.20 to $5.45 through 2032. The $3.33 average target implies a +26% move from current prices. That is -1% versus the projected 2031 average. Momentum favours further upside here.
The QTRX price prediction for 2033 points to an average of $3.03 (low $1.95, high $5.07) — a potential gain of +14% on today's $2.65. A consolidation phase looks the most probable path here.
In 2034, QTRX is projected to trade between $2.19 and $5.92, averaging $3.47 — a potential gain of +31% from today's $2.65. That is up +15% on the projected 2033 average. Momentum favours further upside here.
Quanterix Corporation's 2035 outlook centres on $3.86, within a $2.39 to $6.71 range. That is up +11% on the projected 2034 average. That marks a +46% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, QTRX could reach as high as $8.23, with a base case around $4.39 and support toward $2.45 — roughly +66% from $2.65. Momentum favours further upside here.
Expect QTRX to range from $4.43 to $19.85 through 2050. The $9.52 average target implies a +259% move from current prices. That is up +117% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in QTRX today (≈ 377.358491 QTRX) could be worth
$3,592.6
+$2,592.6 (+259%) by 2050 · US Dollar
Based on the average projected QTRX price of $9.52 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in QTRXwould be worth at today's price.
$1,000 invested in QTRX on May 27, 2025 (≈ 196.656832 QTRX) would be worth
$521.14
-$478.86 (-47.9%) today · 0.52× · US Dollar
Based on a QTRX entry price of $5.09 vs. today's $2.65.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.52 | $1,051.59 | +5.2% |
| 1 month ago | $3.21 | $825.55 | -17.4% |
| 3 months ago | $6.72 | $394.35 | -60.6% |
| 6 months ago | $7.26 | $365.01 | -63.5% |
| 1 year ago | $5.09 | $521.14 | -47.9% |
| All time (5.0y) ago | $49.85 | $53.16 | -94.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our QTRX forecast.
Our base-case forecast reaches $5.30 around 2050.
Implied market cap at $5.30: $249.66M
Looking further out, the multi-year forecast shows mixed to bullish momentum entering the late 2020s and expanding through the 2030s and beyond. The 2026 average is $2.69, with 2027 at $2.46 (ROI -8.5%), 2028 at $2.95 (ROI 9.5%), and 2029 at $3.68 (ROI 36.7%), indicating a shift toward stronger gains later in the decade and beyond.
From 2030 onward, the forecast depicts continued upside with 2030 average at $3.40 (ROI 26.3%), 2031 at $3.43 (ROI 27.5%), 2032 at $3.38 (ROI 25.5%), and 2034 at $3.54 (ROI 31.6%), followed by 2035 at $3.93 (ROI 46.1%). The momentum persists into 2040 with an average of $4.50 (ROI 67.3%). By 2050, the average price is projected to $9.70 (ROI 260.7%), with a maximum forecast of $20.80 and a bullish sentiment.
Overall, the long-term view suggests substantial upside potential over the coming decades, but it also includes periods of slower growth or pullbacks in the near term. These are estimates and not guarantees, and actual results may differ due to market dynamics and other factors.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $3.40 with a minimum of $2.32 and a maximum of $5.39, and an estimated ROI of 26.3% with bullish sentiment.
Forecasts show mixed near term (e.g., 2026 average $2.69, 0% ROI; 2027 average $2.46, -8.5% ROI) but bullish momentum in several later years (e.g., 2029 average $3.68, 36.7% ROI; 2040 average $4.50, 67.3% ROI; 2050 average $9.70, 260.7% ROI). These are estimates, not guarantees.
Yes, the 2050 forecast shows a maximum of $20.80 and an average of $9.70, indicating potential to exceed $10 within the forecast horizon, though not guaranteed.
Current price is $2.69 and market capitalization is $126.72M.
The sentiment is NEUTRAL with RSI(14) at 40. The SMA50 is $3.40 and the SMA200 is $5.28, with support at $2.51 and resistance at $3.60. The 30-day range is $2.08 to $3.48, and volatility is 70%.
Quanterix Corporation Community Discussion
0Share your Quanterix Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.